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This qualitative study explores corporations’ motivations to comply with new natural health products
(NHP) Regulations in Canada. Interviews were conducted with representatives from 20 Canadian NHP
companies. Findings show that the rationale for compliance differs for large compared to small and
medium-sized enterprises (SMEs). Large firms are motivated to comply with the regulations because of
the deterrent fear of negative media coverage, social motivations, ability to comply and maintaining a
competitive market advantage. In contrast, SMEs are motivated to comply due to the deterrent fear of
legal prosecution and a sense of duty.
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Introduction
New regulations require adherence in order to be effective.
Debate continues about how best to ensure compliance of
target groups with government regulations. Some argue that
governments must guarantee that regulations are effectively
enforced through appropriate monitoring and sanctions (1,2).
Others believe that target groups will comply with regulations,
regardless of government actions. For example, the Harrington
Paradox describes how most firms comply with the Envi-
ronmental Protection Agency (EPA) programs of the United
States, despite the minimal penalties and few violators actually
sought out by the EPA (3). Despite this, regulatory scholars
have traditionally studied the enforcement strategy of the
agency responsible for implementing regulations (4,5). More
recent accounts have focused on the compliance of target
groups with regulations. For example, Laeeque et al. (6)
describes who appears to be complying with the new Canadian
Natural Health Product (NHP) regulations and identifies
factors such as firm size and knowledge of the regulations
that are associated with likelihood of compliance. One
question that remains is why do firms attempt to comply with
regulations? This paper sheds light on the debate by exploring
the motivations of Canadian firms for complying with the
NHP Regulations. Understanding what variables motivate
industry compliance can help inform the implementation and
enforcement stages of the Regulations (7).
Background
This study focuses on compliance with Canada’s new NHP
Regulations and the new requirements of the NHP industry,
which are described below.
The Natural Health Products Regulations
The NHP Regulations were implemented on January 1, 2004
by Health Canada. NHPs, now a subcategory of drugs, are
defined in the Regulations as products such as vitamins,
minerals, homeopathic medicines and others. The most
important aspect of the regulations is the requirement for pre-
market approval from the Natural Health Products Directorate
(NHPD) of Health Canada for all NHP products new to the
Canadian market and re-approval of all existing products
during a 6 year transition period. A company that sells a NHP
on the Canadian market must obtain a natural product number
(NPN) from the NHPD for all new and existing NHP products.
This number is granted upon submission of a product licence
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efficacy of the product. The first compliance deadline for
submitting a PLA for high-risk products was June 30, 2004.
Each NHP sold in Canada must have a product licence by
January 2010.
In addition to completing PLAs for each of their products,
companies that manufacture, package, label or import NHPs
were required to apply for site licenses by December 31, 2005.
To be granted a license, the site must demonstrate compliance
with good manufacturing practices (GMPs) through submis-
sion of a quality assurance report prepared by an individual
with appropriate training, education and/or experience in
GMPs. GMPs were developed to be appropriate for NHPs,
and include standards on cleanliness, quality assurance and
record-keeping. Details of the GMP standards are available on
Health Canada’s web site (http://www.hc-sc.gc.ca/dhp-mps/
prodnatur/legislation/docs/gmp-bpf_e.html) and include
employing measures to ensure an effective overall approach
to product quality control and risk management. For example,
the company must have clear procedures in place to maintain
distribution records and facilitate product recalls.
Overview of the NHP Industry in Canada
Information on the NHP industry in Canada is limited because
provincial drug plans do not reimburse purchases of NHPs and
neither the industry nor the government monitor annual sales
of NHPs (8). Prior to implementing the NHP Regulations,
Health Canada conducted a Business Impact Test (BIT) to
predict the impact of the Regulations at the industry level. The
BIT described the NHP industry as comprised mainly of small
and cottage businesses. For example, 55% of respondents were
with a company with fewer than 19 employees. Furthermore,
75% of respondents said their company had fewer than 50
employees. The BIT defined small business as firms with less
than 20 employees, medium size firms as having 20–49
employees, and large firms as greater than 50 employees.
The NHP Regulations represent a significant change in
regulatory burden for this industry. In many cases, companies
need to make significant changes in their operations. It is
important to note that the data collection for this study was in
the first year of a 6year phase-in of the new regulations. At this
time, there was much concern over how NHP companies
would respond to the new standards. Thus, company motiva-
tions to make these changes appeared important to explore.
Four main compliance motivations identified in the literature
are as follows: deterrent fears, duty to comply, social
motivations and ability to comply.
Motivations for Compliance
Deterrent Fears
General deterrence theory is based on the assumption that
businesses are profit-driven and that regulatory compliance at
the firm level occurs when non-compliance costs, through the
form of fines, sanctions or imprisonment, exceed compliance
costs (9). Deterrent fears develop from the fear of negative
outcomes due to non-compliance with regulations. Fear can
be either specific, due to enforcement actions on individual
firms, or general, from the regulations. General deterrence
fears include: fear among the regulated group because of the
expectation that violators of the law will be persecuted, fear
from exposure of non-compliance via lawsuits, or fear from
the perception of forthcoming imposing regulations (1,10). No
research has been conducted on deterrence and compliance
behavior during the early implementation stage of regulations.
Duty to Comply
An important aspect of effective regulations is that citizens
feel a need for the regulations, and that firms recognize their
responsibility to comply. This motivation reflects the value
system of the regulated individuals. Two factors are important
in this motivation: the individual/firm’s general principles
regarding one’s civic duty to comply with laws and one’s
perceptions about the legitimacy of the law in question (7,10).
Inherent in the obligation to conform to regulations is that the
regulated firms understand the need for regulation in order to
prevent public harm (7,10). Duty to comply with regulations
has also been called normative motivation, moral or ideologi-
cal compliance, or perceived obligation.
Social Motivations
Social motivations occur whena firm/individual complies with
the rules in order to gain the respect of other individuals or
groups, regardless of whether the complying firm agrees
with the regulations. Winter and May (2001) state that social
motivations may be instigated by other firms, trade associa-
tions, regulatory inspectors, external advocacy groups, the
media, family and friends.
Ability to Comply
Given the diversity of firm size and location within a particular
industry, some firms will be more capable of complying with
regulations in comparison to other firms. Ability to comply
with regulations is mainly affected by knowledge of the
regulations and the financial/technical resources of a firm. As
reported in a previous paper, we found that NHP firms that
were non-compliant with the NHP Regulations were unaware
of their responsibilities, rather than intentionally avoiding
compliance (6). Thus, employees must be aware of the regu-
lations and understand their complexities as a precursor to
regulatory compliance. That is, compliance with regulations
is only likely when feasible for a firm.
Two other factors may influence the motivation to comply.
These factors are as follows: enforcement practices of the
regulatory agency and the attitudes and beliefs of regulated
entities (10). These motivations and factors may interact in
complex ways. For example, knowledge of the rules may have
a positive effect on deterrent fears. Or, acceptance and trust
among the regulated about inspectors may positively affect
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interactions have not been studied to a great extent and require
further research.
Methods
An applied ethnography (11) was employed that incorporates
qualitative research methods in order to explore the motiva-
tions of NHP companies that are complying with the new
Regulations.
Interview Sample
Criterion-based, purposeful sampling (12) based on business
size, location and specialty was used to select NHP companies.
Companies that sold chondroitin and/or glucosamine were
selectively chosen because a PLA for these products was
required to be submitted by the first compliance deadline of
June 30, 2004. Of the  364 NHP businesses in Canada, 65 met
the eligibility criteria of the study, which were (i) manu-
factures, packages or labels glucosamine or chondroitin,
(ii) located in Canada and (iii) able to participate in an
interview in English.
Semi-structured interviews were conducted either by tele-
phone or in-person with the person responsible for regulatory
affairs and/or writing the NPN applications. Interviews were
continued until data ‘saturation’ was reached. Saturation is the
point at which no new information is being identified with
respect to the key themes emerging from the data analysis (13).
This is normally expected after completion of 15–30 inter-
views. The interviews were scheduled for  1 h and were
audiotaped and transcribed verbatim.
Data Gathering and Analysis
Corporate motivations were identified through direct ques-
tioning in interviews and by spontaneous comments of
participants regarding their decision to comply with the
Regulations. Participants also completed a form regarding
the number and date by which the company submitted PLAs
for chondroitin and glucosamine. Data collected from the
interviews were independently analyzed and coded by three
different researchers using qualitative content analysis (14).
The data from interviews were stored and managed using
NVIVO (15).
It should be noted that this study is unique because it was
conducted at the very early stages of a 6-year implementation
period. It is possible that motivations for compliance may
change later in the implementation period or after the new
NHP Regulations have been fully implemented. Our results
provide insight into why companies are (or are not) attempting
to comply early in the implementation process.
Results
Companies Interviewed
Figure 1 depicts the companies interviewed. NHP companies
of various locations, specialties and sizes were included
(Table 1). The majority of companies that were involved in
the study are based in Ontario (n ¼ 11), British Columbia
(n ¼ 3) and Quebec (n ¼ 3); however, companies in Alberta
and Manitoba were also interviewed. Companies interviewed
also ranged in size and included nine defined as large, six
defined as medium and five defined as small businesses. The
smallest company interviewed had only 3 employees and the
largest company employed over 500 people. Overall, most of
the companies in the study are responsible for several hundred
NHP products and have annual sales of less than 10 million.
However, company sales ranged from less than half a million
dollars to over 200 million in annual sales. Most of the
companies primarily focus their sales in Canada. Seventeen of
the 20 companies interviewed were attempting to comply with
the new regulations (6).
 
Figure 1. Number of companies interviewed for the study (6) taken from Laeeque et al. [The Canadian Natural Health Products Regulations: industry perceptions
and compliance factors. BMC Health Serv Res 2006;6:63].
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Given the similarity in their perceptions, findings from
interviews of individuals from small and medium companies
have been combined and are referred to as small and medium-
sized enterprises (SMEs). These findings are contrasted with
findings from large companies.
Large Companies
Participants from large companies expressed the following
four main reasons for deciding to comply with the NHP
Regulations: deterrent fears, social motivations, the ability to
comply and maintaining a competitive advantage.
Deterrent Fear of Negative Media Coverage
One participant stated that failure to comply with the
Regulations would lead to harmful media coverage of the
company and their products. Thus, the company has decided to
comply with the Regulations to be protected from damaging
media reports of non-compliance.
Social Motivation: Increasing Consumer Confidence of
NHPs and the Industry
Other reasons for complying with the Regulations were social
in nature. A few large firm representatives felt that companies
should comply with the Regulations because consumers need
to know that when they purchase a product, what is written on
the label is contained in the product.
The reason we are going forward is, we believe it
[NHP Regulations] needs to be implemented....The
consumer that buys ...a brand and they don’t have a
benefit, they will say, ‘glucosamine doesn’t work.’ So
now they don’t use the product anymore....So unless
we get the Regulations in place we are not going to
keep the consumer base. We will kill our own brands.
That is why our company is still going forward. (Firm
15, Large)
Ability to Comply
Some participants simply stated that the firm is already
compliant with the NHP standards. All of the large firms in the
study have either vitamin or mineral products with a Drug
Identification Number (DIN) and thus are compliant with the
drug regulations under the Food and Drugs Act. Thus,
adhering to the new NHP Regulations was not a major
undertaking for the firm:
We did comply with good manufacturing practices
for all our DIN products in the past. We are probably
more stringent than the current NHP guidelines
because we have produced DIN products for all our
vitamins and mineral supplements. To adhere to the
new licence requirements I don’t think was a major
undertaking. (Firm 12, Large)
Maintaining a Competitive Advantage
For strategic reasons, many large firms have decided to
embrace the Regulations, and attempt to gain a market
advantage over other firms. A perceived market advantage is
gained because a company that obtains a NPN is able to sell the
product with a new health claim before other companies. The
NPN is considered a positive feature of the product and
industry members assume consumers will respond favorably to
a product with an NPN versus a product without a NPN:
The whole point of applying [for a NPN] isn’t to
become compliant with the Regulations. It’s not to
get your red tape out of the way. That’s not why
everyone is rushing to comply. The whole point of
applying [for a NPN] is to get your claim. So you can
say ‘this product cures cancer’ compliantly, or
whatever your claim is. That’s the whole point- it’s
all marketing driven. (Firm 4b, Large)
Another strategic reason to comply with the Regulations is
to maintain a key position within the NHP industry. Many
participants felt that the process of attaining a product licence
Table 1. Company characteristics of the 20 interviewed companies (6)
Description No. of companies
Size
Small (<19 employees) 5
Medium (20–49 employees) 6
















Taken from Laeeque et al. (6).
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longer be able to comply with the Regulations and survive in
the industry. Thus, a firm can sustain a good position in
the NHP industry by complying with the standards of the
Regulations and encouraging other firms to follow the
standards and squeeze others out of the market:
They [the NHPD] don’t know what to expect and by
us being in there early, working with them [the
NHPD], we are actually helping them define what
information should be expected. And we want to set
the bar high. (Firm 4a, Large)
SMEs
Unlike large firms, three SMEs were non-compliant with the
NHP Regulations due to lack of knowledge of their
responsibilities. These SMEs did not invest the time required
to learn about the new Regulations. SMEs’ motivations for
compliance also differed from large firms. SMEs are comply-
ing with the NHP Regulations because of deterrent fears and
the duty to comply with Regulations.
Deterrent Fears
SMEs employees were also motivated by deterrent fears.
Participants felt that enforcement actions, such as preventing
the sale of some NHPs that have an extensive history of use in
humans, are unfair. Employees of SMEs are particularly
fearful of inspections and the level of strictness of enforcement
actions.
Duty to Comply
Representatives from SMEs are complying with the Regula-
tions because of their legal responsibilities. A participant
explains:
[the NHP Regulations] are the laws governed by the
country and basically what I am doing here is saying
‘okay, how do I do that? What process do I do to meet
that law?’ (Firm 7, Small)
Discussion
The main finding of this paper is that the motivations for
compliance for large firms differ from compliance motivations
of SMEs. The four motivations of corporate compliance are
discussed below.
Deterrent Fears
Both large firms and SMEs were motivated by general
deterrent fears (rather than specific deterrence), although the
type of motivating fear differs. Large firm representatives
were fearful of negative media coverage if the firm were found
to be non-compliant with the Regulations, a fear that has not
been identified in previous research. SMEs were fearful of
enforcement actions. In essence, both firm types are concerned
about the reputation of their business with either consumers
or government officials. Studies of other industry sectors
have reported similar results. For example, in the chemical
and electroplating industries which have been subject to over
20 years of government regulation, SMEs were more
responsive to deterrence compared to large firms that were
concerned about maintaining the trust of the public (16). Thus,
differences in the type of deterrence fears of large firms and
SMEs may continue from the early to the later stages of
regulatory implementation.
Duty to Comply
For SMEs that were aware of their regulatory responsibilities,
a strong motivation for compliance is their legal duty to
comply with the Regulations. Duty to comply is related to
one’s understanding of civic duties and the perceptions of the
legitimacy of the law. As shown previously, all participants in
the study felt that the Regulations are necessary (6). Therefore,
the duty to comply may be more influenced by one’s sense of
responsibility rather than the legitimacy of the law.
Social Motivations
Large firm representatives were motivated to comply with
the Regulations because they wanted to enhance the public
perception of NHPs and supporting the NHP Regulations was
seen to be one way to do this. NHPs and complementary/
alternative medicine in general are increasingly considered
part of health care systems around the world (17) and regu-
lations that enhance the quality of NHPs are generally seen as
a necessary step in this process. This is not to say that SMEs
were not motivated by social causes but that social motivations
appear to be more contributory to compliance for large firms
than SMEs.
Ability to Comply
The ability to comply with regulations is affected by a firm’s
administrative infrastructure and knowledge of the require-
ments. Large firms are better able to comply with the
Regulations compared to SMEs because employees are
familiar with the drug regulations and several have had
products registeredas drugs. Thus, large firms already have the
resources in place to be fully compliant. The ability to comply
appears to be the main motivating factor for large firms. In
contrast, SMEs are being exposed to a new set of regulations
without any previous experience.
Laeeque et al. (6) explored the factors that are important
for regulatory compliance by comparing responses of non-
compliant companies with compliant companies. The import-
ant factors for firm compliance were found to be perceptions of
the regulations, business size and knowledge of the regula-
tions. This study highlights the central role that knowledge of
eCAM 2007;(4)2 261the regulations (correlated closely with firm size) has on
ability to comply and thus motivation to attempt to comply
with regulation.
Research Limitations
The major limitation of the study is the large number of
participant refusals. However, in the study, a maximum
variation sample and saturation are achieved, ensuring that a
range of opinions and perceptions are captured.
Conclusion
This study probed the motivations for firm compliance with
regulatory requirements. Firms comply for different reasons
and these vary according to business size for the Canadian
NHP regulations. Large firms are motivated to comply with
the regulations for reputation reasons (e.g. fear of negative
media coverage), social motivations, the fact that they have the
resources to comply with relative ease and the belief that
complying will result in a potential competitive advantage.
Motivations for SMEs differ in that they are more likely to be
due to fears of legal prosecution if they are non-compliant and
also a corporate duty to comply with the law.
Consumer perceptions and media coverage of compliance
status are important factors for policymakers to consider when
planning compliance strategies. Strict enforcement policies,
such as inspections of industry premises, are expensive and
time-consuming for a regulatory body, but likely necessary to
ensure compliance. However, successful implementation of
regulations requires creative actions of the implementing
agency to stimulate the motivations of various sized firms. For
example, publicly available lists of products that have been
approved or companies with site licenses may enhance the
likelihood of compliance more effectively than increasing
enforcement strategies.
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